News & Perspective

Mar 28, 2011

Mar 28, 2011

WHO pandemic reviewers field comments on preview report

(CIDRAP News) – The independent committee reviewing the World Health Organization's (WHO's) performance during the 2009 H1N1 pandemic today at a meeting in Geneva received feedback from countries and organizations on its preliminary report, which was released Mar 10 and generally defended the WHO's actions. The feed back mostly consisted of questions and clarifications.

Mar 10, 2011

Mar 10, 2011

Pandemic review committee defends WHO response

(CIDRAP News) – An external committee reviewing the World Health Organization's (WHO's) performance during the H1N1 pandemic released a preview of its findings today, which defends the WHO against criticism that it overstated the pandemic threat and recommends that it take several steps to improve future response.

Mar 02, 2011

Mar 02, 2011

Study finds H1N1 and H9N2 offspring can be more lethal

(CIDRAP News) – Chinese researchers who tested reassortants that combined the 2009 H1N1 virus with H9N2, a subtype that commonly circulates in birds, found that several were more pathogenic then the parent viruses, which they said could pose a pandemic threat.

Feb 02, 2011

Feb 02, 2011

Study traces variation in pandemic school closures

(CIDRAP News) – A study that put school closures during the 2009 H1N1 pandemic under the microscope says that jurisdictions varied in their reasons for shuttering schools and that officials often were uncertain about who had authority to make the decision and what federal guidance was in place.

Jan 28, 2011

Jan 28, 2011

Experts air kinks in antiviral use during H1N1 pandemic

(CIDRAP News) – Although antiviral drugs were used to treat many seriously sick people during the H1N1 influenza pandemic, experts at a conference today said they could have been used more widely and that some opportunities to learn from their use were missed.

Jan 28, 2011

Jan 28, 2011

IOM report spells out priorities for flu PPE research

(CIDRAP News) – The 2009 H1N1 pandemic brought to light ongoing controversies about the best use of personal protective equipment (PPE) in healthcare settings, and yesterday an expert group released a report that they hope will guide research priorities in the years ahead.

Jan 27, 2011

Jan 27, 2011

CDC officials share key pandemic communications lessons

(CIDRAP News) – Two federal officials who frequently appeared on television as top sources during the 2009 H1N1 pandemic provided a rare glimpse behind the curtain at some of the event's pivotal moments today during a panel discussion at an infectious disease conference in Washington, DC.

Jan 11, 2011

Jan 11, 2011

European study says H1N1 vaccine offered good protection

(CIDRAP News) – In the largest study of its kind so far to assess how well 2009 H1N1 vaccines performed in the pandemic setting, new findings from seven European countries showed they provided good protection, a result that mirrors early clinical studies.

Dec 30, 2010

Dec 30, 2010

Reports call Canada's pandemic response effective, cite gaps

(CIDRAP News) – In two new reports, the Canadian government gives itself a generally good grade for its response to the H1N1 pandemic but also lists many areas for improvement.

"Overall, the response of [health authorities] to the H1N1 pandemic is considered to have been effective," says the Public Health Agency of Canada's (PHAC's) report, released yesterday. The report covers the actions of that agency and of Health Canada.

Dec 14, 2010

Dec 14, 2010

Studies show science behind CDC pandemic response

(CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) today published a detailed look at the early field and epidemiologic studies it used to guide its response to the 2009 H1N1 pandemic, such as spread among household contacts, disease severity, and the impact on high-risk groups.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»